Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F7PVF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,404
Award facts
- Contract value 100% obligated
- $44,404.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $44,404.42 delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for Cosentyx 300mg dose (cosentisumab) supply.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical and medical supply delivery to military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of February 24, 2026.
Quick answers
Who was awarded contract SPE2DR26F7PVF?
SPE2DR26F7PVF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 23, 2026.
How much is contract SPE2DR26F7PVF worth?
The government has obligated $44,404 on SPE2DR26F7PVF.
Is contract SPE2DR26F7PVF an order under another contract?
Yes. SPE2DR26F7PVF is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7PVF competed?
The extent of competition for SPE2DR26F7PVF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award